R Asero Selected Research

Chronic Urticaria

1/2022	Nonsteroidal anti-inflammatory drugs hypersensitivity in chronic spontaneous urticaria in the light of its pathogenesis.
1/2022	Clinical variables of severe chronic spontaneous urticaria from total IgE standpoint: a retrospective study.
11/2021	Omalizumab in severe chronic urticaria: are slow and non-responders different?
1/2021	Chronic spontaneous urticaria treated with omalizumab: what differentiates early from late responders?
11/2020	Are currently available biomarkers useful to discriminate CSU patients not controlled by low dose omalizumab maintenance therapy?
1/2020	Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.
1/2020	Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence.
5/2019	Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.
1/2018	IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria.
1/2018	Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticaria.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Asero Research Topics

Disease

77	Hypersensitivity (Allergy) 01/2022 - 04/2000
41	Chronic Urticaria 01/2022 - 08/2000
19	Food Hypersensitivity (Food Allergy) 01/2018 - 04/2000
18	Urticaria (Hives) 01/2020 - 08/2000
7	Asthma (Bronchial Asthma) 01/2022 - 01/2004
7	Anaphylaxis (Anaphylactic Shock) 01/2020 - 11/2006
5	Seasonal Allergic Rhinitis (Hay Fever) 01/2018 - 04/2000
3	Rhinitis 01/2022 - 01/2001
3	Atopic Dermatitis (Atopic Eczema) 04/2020 - 08/2010
3	Angioedema 01/2018 - 08/2000
3	Inflammation (Inflammations) 10/2012 - 03/2001
3	Pruritus (Itching) 10/2006 - 03/2001
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2013
2	Insect Bites and Stings (Insect Bite) 01/2020 - 01/2016
2	Peanut Hypersensitivity (Peanut Allergy) 04/2015 - 08/2009
1	Perennial Allergic Rhinitis 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Cold Urticaria 04/2020
1	red meat allergy 11/2017
1	Tick Bites 11/2017
1	Infections 04/2015
1	Drug-Related Side Effects and Adverse Reactions 03/2015
1	Bites and Stings (Sting) 01/2012
1	type 2C Congenital disorder of glycosylation 12/2011
1	Confusion (Bewilderment) 01/2010

Drug/Important Bio-Agent (IBA)

37	Immunoglobulin E (IgE)IBA 01/2022 - 01/2001
36	AllergensIBA 01/2022 - 03/2001
16	lipid transfer protein (glycolipid transfer protein)IBA 01/2022 - 04/2006
14	Profilins (Profilin)IBA 01/2018 - 10/2002
14	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2001
13	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 08/2000
13	Omalizumab (Xolair)FDA Link 01/2022 - 01/2014
10	Histamine (Histamine Dihydrochloride)FDA Link 01/2012 - 03/2001
8	AutoantibodiesIBA 01/2020 - 04/2009
7	Pharmaceutical PreparationsIBA 11/2020 - 06/2005
6	fibrin fragment D (D-dimer)IBA 01/2018 - 02/2008
6	LipidsIBA 08/2015 - 07/2001
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 08/2000
5	Histamine Antagonists (Antihistamines)IBA 01/2012 - 01/2007
4	ragweed pollenIBA 08/2012 - 04/2000
3	EnzymesIBA 01/2022 - 10/2002
3	TropomyosinIBA 01/2020 - 01/2012
3	Arthropod VenomsIBA 01/2016 - 12/2004
3	Epinephrine (Adrenaline)FDA LinkGeneric 06/2015 - 06/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014 - 09/2005
3	C-Reactive ProteinIBA 10/2012 - 06/2010
3	LatexIBA 04/2012 - 04/2007
3	nimesulide (Aulin)IBA 10/2010 - 08/2000
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2010 - 08/2000
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 07/2008
2	Immunoglobulin G (IgG)IBA 01/2020 - 07/2008
2	Tryptases (Tryptase)IBA 01/2020 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2014
2	IgE Receptors (Fc epsilon RI)IBA 01/2016 - 12/2011
2	Complement System Proteins (Complement)IBA 05/2015 - 07/2001
2	PropionatesIBA 03/2015 - 06/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2013 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 11/2009
2	Prothrombin (Factor II)IBA 10/2011 - 02/2011
2	Cetirizine (Zyrtec)FDA LinkGeneric 10/2010 - 01/2007
2	Translationally-Controlled 1 Tumor ProteinIBA 09/2007 - 03/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007 - 09/2005
2	SteroidsIBA 01/2007 - 09/2005
2	Piroxicam (Feldene)FDA LinkGeneric 06/2005 - 08/2000
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 05/2001 - 08/2000
1	P 11 (P-11)IBA 01/2022
1	Pyridinolcarbamate (P23)IBA 01/2022
1	Dermatophagoides farinae antigen f 2IBA 01/2022
1	Dermatophagoides farinae antigen f 1IBA 01/2022
1	Dermatophagoides pteronyssinus antigen p 7IBA 01/2022
1	Dermatophagoides pteronyssinus antigen p 5IBA 01/2022
1	Dermatophagoides pteronyssinus antigen p 2IBA 01/2022
1	Dermatophagoides pteronyssinus antigen p 1IBA 01/2022
1	dupilumabIBA 04/2020
1	Biological ProductsIBA 01/2020
1	Cetuximab (Erbitux)FDA Link 11/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2017
1	anti-IgE antibodiesIBA 04/2015
1	HemocyaninsIBA 09/2014
1	Arginine KinaseIBA 09/2014
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 09/2014
1	Calcium-Binding ProteinsIBA 09/2014
1	Fibrin Fibrinogen Degradation ProductsIBA 06/2014
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2013
1	CCR3 ReceptorsIBA 10/2012
1	sterol carrier proteinsIBA 09/2012
1	Environmental Pollutants (Pollutants, Environmental)IBA 07/2012
1	Carrier Proteins (Binding Protein)IBA 02/2011
1	Tramadol (K315)FDA LinkGeneric 10/2010
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 10/2010
1	Serum AlbuminIBA 08/2010
1	EndopeptidasesIBA 06/2010
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010

Therapy/Procedure

5	Immunotherapy 01/2013 - 04/2000
2	Intradermal Injections 02/2011 - 12/2009
1	Therapeutics 11/2020
1	Retreatment 01/2020
1	Premedication 10/2010
1	Photochemotherapy (Photodynamic Therapy) 08/2010